Show simple item record

dc.creatorMiller, Henry I.en
dc.date.accessioned2011-07-12T18:26:36Zen
dc.date.available2011-07-12T18:26:36Zen
dc.date.created2003-05en
dc.date.issued2003-05en
dc.identifier.bibliographicCitationNature Biotechnology 2003 May; 21(5): 480-481en
dc.identifier.urihttp://hdl.handle.net/10822/523603en
dc.descriptionopinionen
dc.description.urihttp://dx.doi.org/10.1038/nbt0503-480en
dc.formatArticleen
dc.languageengen
dc.source259588en
dc.subject.classificationTechnology Assessmenten
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationBiohazards of Genetic Researchen
dc.titleWill we reap what biopharming sows?en
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885